Venitius Nunez, MD
Psychiatry · Camden, NJNPI 1407973035
Payments from drug & device makers
Across 1,134 payments — averaging $13.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$2K
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $5K from 15 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 150 | $2,447 |
| Alkermes, Inc. | 131 | $1,963 |
| AbbVie(2 entities) | 153 | $1,760 |
| Sunovion Pharmaceuticals Inc. | 147 | $1,703 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 118 | $1,614 |
| Otsuka America Pharmaceutical, Inc. | 97 | $1,470 |
| Neurocrine Biosciences, Inc. | 81 | $1,002 |
| Vanda Pharmaceuticals Inc. | 67 | $968 |
| Johnson & Johnson | 60 | $955 |
| Lundbeck LLC | 45 | $534 |
| E.r. Squibb & Sons, L.L.C. | 26 | $365 |
| Noven Therapeutics, LLC | 19 | $245 |
| Indivior Inc. | 11 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $149 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $99 |
| Axsome Therapeutics, Inc. | 5 | $73 |
| Almatica Pharma LLC | 5 | $66 |
| Brainsway USA Inc | 1 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
| Noven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$15,664 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Camden
- Tapan ParikhCamden$275K
- Anthony RostainCamden$110K
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.